Development of a Translational Medicine Protocol for an NCTN Genitourinary Clinical Trial: Critical Steps, Common Pitfalls and a Basic Guide to Translational Clinical Research

od Meeks, Joshua J., Goldkorn, Amir, Aparicio, Ana M., McConkey, David J.
izdano v Urol Oncol (2018)

Function of Tumor Suppressors in Resistance to Antiandrogen Therapy and Luminal Epithelial Plasticity of Aggressive Variant Neuroendocrine Prostate Cancers

od Soundararajan, Rama, Aparicio, Ana M., Logothetis, Christopher J., Mani, Sendurai A., Maity, Sankar N.
izdano v Front Oncol (2018)

Candidate pathways and genes for prostate cancer: a meta-analysis of gene expression data

od Gorlov, Ivan P, Byun, Jinyoung, Gorlova, Olga Y, Aparicio, Ana M, Efstathiou, Eleni, Logothetis, Christopher J
Izdano 2009

Epigenetics in Prostate Cancer

od Albany, Costantine, Alva, Ajjai S., Aparicio, Ana M., Singal, Rakesh, Yellapragada, Sarvari, Sonpavde, Guru, Hahn, Noah M.
Izdano 2011

Combination Platinum-based and DNA Damage Response-targeting Cancer Therapy: Evolution and Future Directions

od Basourakos, Spyridon P., Li, Likun, Aparicio, Ana M., Corn, Paul G., Kim, Jeri, Thompson, Timothy C.
izdano v Curr Med Chem (2017)

Phase II Trial of Sorafenib in Combination with Carboplatin and Paclitaxel in Patients with Metastatic Uveal Melanoma: SWOG S0512

od Bhatia, Shailender, Moon, James, Margolin, Kim A., Weber, Jeffrey S., Lao, Christopher D., Othus, Megan, Aparicio, Ana M., Ribas, Antoni, Sondak, Vernon K.
Izdano 2012

Large Extracellular Vesicle Characterization and Association with Circulating Tumor Cells in Metastatic Castrate Resistant Prostate Cancer

od Gerdtsson, Anna S., Setayesh, Sonia M., Malihi, Paymaneh D., Ruiz, Carmen, Carlsson, Anders, Nevarez, Rafael, Matsumoto, Nicholas, Gerdtsson, Erik, Zurita, Amado, Logothetis, Christopher, Corn, Paul G., Aparicio, Ana M., Hicks, James, Kuhn, Peter
izdano v Cancers (Basel) (2021)

Combined Tumor Suppressor Defects Characterize Clinically Defined Aggressive Variant Prostate Cancers

od Aparicio, Ana M., Shen, Li, Tapia, Elsa Li Ning, Lu, Jing-Fang, Chen, Hsiang-Chun, Zhang, Jiexin, Wu, Guanglin, Wang, Xuemei, Troncoso, Patricia, Corn, Paul, Thompson, Timothy C., Broom, Bradley, Baggerly, Keith, Maity, Sankar N., Logothetis, Christopher J.
izdano v Clin Cancer Res (2015)

Cabazitaxel plus carboplatin for the treatment of men with metastatic castration-resistant prostate cancers: a randomised, open-label, phase 1–2 trial

od Corn, Paul G, Heath, Elisabeth I, Zurita, Amado, Ramesh, Naveen, Xiao, Lianchun, Sei, Emi, Li-Ning-Tapia, Elsa, Tu, Shi-Ming, Subudhi, Sumit K, Wang, Jennifer, Wang, Xuemei, Efstathiou, Eleni, Thompson, Timothy C, Troncoso, Patricia, Navin, Nicholas, Logothetis, Christopher J, Aparicio, Ana M
izdano v Lancet Oncol (2019)

Single-Cell Circulating Tumor Cell Analysis Reveals Genomic Instability as a Distinctive Feature of Aggressive Prostate Cancer

od Malihi, Paymaneh D., Graf, Ryon P., Rodriguez, Angel, Ramesh, Naveen, Lee, Jerry, Sutton, Ramsay, Jiles, Rhett, Velasco, Carmen Ruiz, Sei, Emi, Kolatkar, Anand, Logothetis, Christopher, Navin, Nicholas E., Corn, Paul, Aparicio, Ana M., Dittamore, Ryan, Hicks, James, Kuhn, Peter, Zurita, Amado J.
izdano v Clin Cancer Res (2020)

Targeting DNA damage response in prostate cancer through inhibition of androgen receptor/CDC6-ATR-Chk1 signaling: Combined AR/CDC6 and Chk1/2 inhibition for PCa

od Karanika, Styliani, Karantanos, Theodoros, Li, Likun, Wang, Jianxiang, Park, Sanghee, Yang, Guang, Zuo, Xuemei, Song, Jian H., Maity, Sankar N., Manyam, Ganiraju C., Broom, Bradley, Aparicio, Ana M., Gallick, Gary, Troncoso, Patricia, Corn, Paul G., Navone, Nora, Zhang, Wei, Li, Shuhua, Thompson., Timothy C.
izdano v Cell Rep (2017)

Platinum-Based Chemotherapy for Variant Castrate-Resistant Prostate Cancer

od Aparicio, Ana M., Harzstark, Andrea L., Corn, Paul G., Wen, Sijin, Araujo, John C., Tu, Shi-Ming, Pagliaro, Lance C., Kim, Jeri, Millikan, Randall E., Ryan, Charles J., Tannir, Nizar M., Zurita, Amado J., Mathew, Paul, Arap, Wadih, Troncoso, Patricia, Thall, Peter F., Logothetis, Christopher J.
Izdano 2013

Durable responses in patients with genitourinary cancers following immune checkpoint therapy rechallenge after moderate-to-severe immune-related adverse events

od Siddiqui, Bilal A, Gheeya, Jinesh S, Goswamy, Rohit, Bathala, Tharakeswara K, Surasi, Devaki Shilpa, Gao, Jianjun, Shah, Amishi, Campbell, Matthew T, Msaouel, Pavlos, Goswami, Sangeeta, Wang, Jennifer, Zurita, Amado J, Jonasch, Eric, Corn, Paul G, Aparicio, Ana M, Siefker-Radtke, Arlene O, Sharma, Padmanee, Subudhi, Sumit K, Tannir, Nizar
izdano v J Immunother Cancer (2021)

Targeting the MYCN-PARP-DNA Damage Response Pathway in Neuroendocrine Prostate Cancer

od Zhang, Wei, Liu, Bo, Wu, Wenhui, Li, Likun, Broom, Bradley M., Basourakos, Spyridon P., Korentzelos, Dimitrios, Luan, Yang, Wang, Jianxiang, Yang, Guang, Park, Sanghee, Azad, Abul Kalam, Cao, Xuhong, Kim, Jeri, Corn, Paul G., Logothetis, Christopher J., Aparicio, Ana M., Chinnaiyan, Arul M., Navone, Nora, Troncoso, Patricia, Thompson, Timothy C.
izdano v Clin Cancer Res (2017)

Targeting Poly (ADP-Ribose) Polymerase and the c-Myb-TopBP1-ATR-Chk1 Signaling Pathway in Castration-Resistant Prostate Cancer

od Li, Likun, Chang, Wenjun, Yang, Guang, Ren, Chengzhen, Park, Sanghee, Karantanos, Theodoros, Karanika, Styliani, Wang, Jianxiang, Yin, Jianhua, Shah, Parantu K., Takahiro, Hirayama, Dobashi, Masato, Zhang, Wenling, Efstathiou, Eleni, Maity, Sankar N., Aparicio, Ana M., Tapia, Elsa M Li Ning, Troncoso, Patricia, Broom, Bradley, Xiao, Lianchun, Lee, Hyun-Sung, Lee, Ju-Seog, Corn, Paul G., Navone, Nora, Thompson, Timothy C.
Izdano 2014

Targeted molecular-genetic imaging and ligand-directed therapy in aggressive variant prostate cancer

od Ferrara, Fortunato, Staquicini, Daniela I., Driessen, Wouter H. P., D’Angelo, Sara, Dobroff, Andrey S., Barry, Marc, Lomo, Lesley C., Staquicini, Fernanda I., Cardó-Vila, Marina, Soghomonyan, Suren, Alauddin, Mian M., Flores, Leo G., Arap, Marco A., Lauer, Richard C., Mathew, Paul, Efstathiou, Eleni, Aparicio, Ana M., Troncoso, Patricia, Navone, Nora M., Logothetis, Christopher J., Marchiò, Serena, Gelovani, Juri G., Sidman, Richard L., Pasqualini, Renata, Arap, Wadih
izdano v Proc Natl Acad Sci U S A (2016)

Enzalutamide-induced “BRCAness” and PARP inhibition is a synthetic lethal therapy for castration-resistant prostate cancer

od Li, Likun, Karanika, Styliani, Yang, Guang, Wang, Jiangxiang, Park, Sanghee, Broom, Bradley, Manyam, Ganiraju C., Wu, Wenhui, Luo, Yong, Basourakos, Spyridon, Song, Jian H., Gallick, Gary E., Karantanos, Theodoros, Korentzelos, Dimitrios, Azad, Abul Kalam, Kim, Jeri, Corn, Paul G., Aparicio, Ana M., Logothesis, Christopher J., Troncoso, Particia, Timothy, Heffernan, Toniatti, Carlo, Lee, Hyun-Sung, Lee, Ju-Seog, Zuo, Xuemei, Chang, Wenjun, Yin, Jianhua, Thompson, Timothy C.
izdano v Sci Signal (2017)

Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Rep...

od Gillessen, Silke, Bossi, Alberto, Davis, Ian D., de Bono, Johann, Fizazi, Karim, James, Nicholas D., Mottet, Nicolas, Shore, Neal, Small, Eric, Smith, Matthew, Sweeney, Christopher, Tombal, Bertrand, Antonarakis, Emmanuel S., Aparicio, Ana M., Armstrong, Andrew J., Attard, Gerhardt, Beer, Tomasz M., Beltran, Himisha, Bjartell, Anders, Blanchard, Pierre, Briganti, Alberto, Bristow, Rob G., Bulbul, Muhammad, Caffo, Orazio, Castellano, Daniel, Castro, Elena, Cheng, Heather H., Chi, Kim N., Chowdhury, Simon, Clarke, Caroline S., Clarke, Noel, Daugaard, Gedske, De Santis, Maria, Duran, Ignacio, Eeles, Ros, Efstathiou, Eleni, Efstathiou, Jason, Ekeke, Onyeanunam Ngozi, Evans, Christopher P., Fanti, Stefano, Feng, Felix Y., Fonteyne, Valerie, Fossati, Nicola, Frydenberg, Mark, George, Daniel, Gleave, Martin, Gravis, Gwenaelle, Halabi, Susan, Heinrich, Daniel, Herrmann, Ken, Higano, Celestia, Hofman, Michael S., Horvath, Lisa G., Hussain, Maha, Jereczek-Fossa, Barbara Alicja, Jones, Robert, Kanesvaran, Ravindran, Kellokumpu-Lehtinen, Pirkko-Liisa, Khauli, Raja B., Klotz, Laurence, Kramer, Gero, Leibowitz, Raya, Logothetis, Christopher J., Mahal, Brandon A., Maluf, Fernando, Mateo, Joaquin, Matheson, David, Mehra, Niven, Merseburger, Axel, Morgans, Alicia K., Morris, Michael J., Mrabti, Hind, Mukherji, Deborah, Murphy, Declan G., Murthy, Vedang, Nguyen, Paul L., Oh, William K., Ost, Piet, O’Sullivan, Joe M., Padhani, Anwar R., Pezaro, Carmel, Poon, Darren M.C., Pritchard, Colin C., Rabah, Danny M., Rathkopf, Dana, Reiter, Robert E., Rubin, Mark. A., Ryan, Charles J., Saad, Fred, Sade, Juan Pablo, Sartor, Oliver A., Scher, Howard I., Sharifi, Nima, Skoneczna, Iwona, Soule, Howard, Spratt, Daniel E., Srinivas, Sandy, Sternberg, Cora N., Steuber, Thomas, Suzuki, Hiroyoshi, Sydes, Matthew R., Taplin, Mary-Ellen, Tilki, Derya, Türkeri, Levent, Turco, Fabio, Uemura, Hiroji, Uemura, Hirotsugu, Ürün, Yüksel, Vale, Claire L., van Oort, Inge, Vapiwala, Neha, Walz, Jochen, Yamoah, Kosj, Ye, Dingwei, Yu, Evan Y., Zapatero, Almudena, Zilli, Thomas, Omlin, Aurelius
izdano v Eur Urol (2023)